The presence of antioxidants during IVF and embryo culture significantly increased embryo quality during development in the laboratory, the study found. [ + ]

The ATCC Genome Portal is a publicly available database of reference-quality genome sequences matched to authenticated ATCC biological materials. [ + ]

The European Medicines Agency has recommended a conditional marketing authorisation for the rVSV-ZEBOV-GP vaccine, shown to be effective in protecting people from the Ebola virus. [ + ]

A new study points to the need for better antibody validation and outlines a process that other labs can use to make sure the antibodies they work with function properly. [ + ]

Plasmodium falciparum is a species of malaria parasite that only infects humans, after switching host from gorillas through a process known as zoonosis around 50,000 years ago. [ + ]

Minister for Education Dan Tehan has announced Australian Government funding for a new series of Australian Research Council (ARC) Centres of Excellence. [ + ]

Inhibiting a cell death pathway called necroptosis could be a new therapeutic approach to treating idiopathic pulmonary fibrosis. [ + ]

A new laboratory tool simultaneously assesses several indicators of HBV infection that are important for optimal patient management. [ + ]

Targeting these pores could make current antibiotics more effective or allow for the development of antibiotic-free drugs that can use these openings. [ + ]

A bidirectional flow of information between the neocortex and hippocampus is fundamental to formation and retrieval of episodic memories, researchers have found. [ + ]

Two Australian scientists have each been awarded $1.25 million CSL Centenary Fellowships to improve treatments for two of the world's biggest health challenges. [ + ]

Bioenergy STRONG aims to empower, share knowledge and connect Australian bioenergy producers, investors, researchers and users to make Australia's bioeconomy world class. [ + ]

The Scopus Researcher Awards recognise outstanding researchers in Australia and New Zealand who have made significant contributions to their fields and areas of research. [ + ]

A brain chemical could be responsible for triggering heart disease and high blood pressure in people with the snoring condition obstructive sleep apnoea. [ + ]

The Melbourne drug development company has announced Dr Tim Oldham as its new CEO and signed a commercial agreement for its i-body platform with GE Healthcare. [ + ]